Clinical Trials
9 trialsNCT04219904 2026-05-20
PET/MRI Scan for the Evaluation of Resectable Stage IA1-IB3 Cervical Cancer
M.D. Anderson Cancer Center
Phase EARLY_PHASE1 Active not recruiting
NCT04459273 2026-02-05
FAPI PET RDRC
Jonsson Comprehensive Cancer Center
Phase 1 Active not recruiting
NCT02285192 2025-12-30
Positron Lymphography Via Intracervical 18F-FDG Injection for Pre-surgical Lymphatic Mapping in Stage IB1 Cervical Cancer and High-grade Endometrial Cancer
Memorial Sloan Kettering Cancer Center
Phase 1 Active not recruiting
NCT07118176 2025-08-12
Determining the Biodistribution of an Imaging Tracer (68Ga-FAPi-46) in Patients With Solid Tumors or Hematologic Cancers
Jonsson Comprehensive Cancer Center
Phase 1 Recruiting
NCT00794339 2023-08-14
ACRIN6682
American College of Radiology
Phase 2 Terminated
NCT01992861 2023-06-26
MRI and PET Imaging in Predicting Treatment Response in Patients With Stage IB-IVA Cervical Cancer
University of Washington
Terminated
NCT03129776 2022-09-22
Hyperpolarized 13C MR Imaging of Lactate in Patients With Locally Advanced Cervical Cancer (LACC) Cervical Cancer
Sunnybrook Health Sciences Centre
Phase 1 Terminated
NCT00978874 2021-06-25
Fluorine F 18 EF5 PET/CT Imaging in Patients With Locally Advanced or Recurrent/Metastatic Cervical Cancer
Abramson Cancer Center at Penn Medicine
Phase NA Terminated
NCT00003429 2015-12-18
PET Scans in Diagnosing Primary or Recurrent Cervical Cancer in Patients Who Are Undergoing Surgery
Memorial Sloan Kettering Cancer Center
Phase NA Completed